Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine ultrasound-guided pudendal nerve block for post-hemorrhoidectomy analgesia
ChiCTR2500103913Phase 4Recruiting
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Jun 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine in hemorrhoid (2 arms), sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Resting Visual Analog Pain Score and Movement Visual Analog Pain Score. Started Jun 2025; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2500103913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103913.